← capex_spike (all companies) · INO (all signals) · all methodology

capex_spike on INOVIO PHARMACEUTICALS, INC. (INO)

SIC 2834 — Pharmaceutical Preparations · CIK 1055726 · default direction: short

Definition

Fires on >50% YoY capex increase. Captures aggressive reinvestment phases — often precedes value destruction in mature industries.

Every time the signal fired on INO

FYFiling dateEvent date1d5d20d60d252d
FY20252026-03-122026-03-12-1.19%-1.79%-36.90%
FY20242025-03-182025-03-18-6.67%-13.81%-16.19%-0.95%-21.43%
FY20232024-03-062024-03-06-8.51%+13.98%+21.07%+2.63%-80.24%
FY20212022-03-012022-03-01-5.86%+0.62%+17.90%-46.60%-59.88%
FY20192020-03-122020-03-12-24.21%-31.68%-14.53%+26.63%+10.53%
FY20172018-03-142018-03-14+8.28%+14.09%+15.44%-0.67%-21.25%
FY20142015-03-162015-03-16+1.66%+5.23%+24.47%+5.23%-22.33%
FY20122013-03-182013-03-18+0.00%+5.66%+1.89%+20.75%+547.17%

Forward returns are stock returns from event date (next trading day after filing). Sign is raw stock direction; the trade direction is in the calibration table below.

Universe-wide calibration (this signal across all companies)

Horizonn eventsGross stock retHit rateTrade dirNet PnLCost (bps)r/σ net
1d2,295+0.01%+43.27%short-0.06%32-0.01
5d2,292-0.85%+41.88%short+0.74%33+0.06
20d2,258-1.91%+41.67%short+2.05%36+0.10
60d2,127+0.65%+44.01%short-0.78%47-0.02
252d2,092+14.03%+44.93%short-14.91%97-0.09

Net PnL is direction × stock return − round-trip execution cost (5 bps half-spread + ADV-tiered borrow). See capex_spike methodology for the full audit.


Data: /api/company/1055726/financials